# Annie Vereecken

> Annie Vereecken is a seed investor in Antwerp backing Medical and Biotechnology. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Location: Antwerp, Belgium
- Total investments: 7
- Last investment: Jul 2025
- Lead investor: 29%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/annie-vereecken-ab8587102/?originalSubdomain=be

Annie Vereecken is a seed investor in Antwerp focused on Medical and Biotechnology. Annie Vereecken

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2M–$6M |
| Series A | $8.2M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 43% |
| Biotechnology | 3 | 43% |
| Hospital | 2 | 29% |
| Life Science | 2 | 29% |
| Chemical | 1 | 14% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 2 | 29% |
| Series A | 2 | 29% |
| Funding Round | 1 | 14% |
| Venture - Series Unknown | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Allegro Biotech | Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells). | $2.4M | Seed | Jul 03, 2025 |  |
| Allegro Biotech | Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells). | $6M | Seed | Apr 25, 2023 |  |
| Ziphius | Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases. | $29.8M | Series A | May 25, 2021 |  |
| Sensolus | Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications. | $4.1M | Venture - Series Unknown | Oct 06, 2020 |  |
| UgenTec | Located on the Corda Campus in Hasselt and actively supported by iMinds and EIT-ICT labs, UgenTec is one of the fastest growing companies of the region. We received multiple awards and scientific and innovation recognitions for our innovative market approach and our paradigm-shifting algorithm innovations. UgenTec delivers an independentdiagnostic platform to help molecular labs with their DNA (PCR) analyses. For every real-time PCR device we can perform a standardized, automated and certified interpretation of all PCR assays. Without additional training a lab technician can reduce the analysis time of a sample set from 1.5 hours to 3 minutes and this with a higher reliability. Thus we spectacularly improve the efficiency of labs and provide the patient with a higher diagnostic certainty. | $8.2M | Series A | Mar 29, 2018 |  |
| PharmaFluidics | Pharmafluidics is a spin-off company of the Vrije Universiteit Brussel, aiming at developing integrated milli- to nano-engineered solutions for mixing, separation and reaction processes. Rooted in chemical engineering with an advanced know-how in micro-fabrication technology, our team specializes in developing high quality and tailor-made solutionsfor any problem in the chemical and life sciences industry potentially benefiting from miniaturization or fine material structuring. | $8M |  | Jan 11, 2018 |  |
| LynxCare | LynxCare is an AI-powered Big Data platform. We enable hospitals to mine their legacy data, to improve clinical efficiency and higher the quality of care. | $2M | Seed |  |  |

7 of 7 investments shown.

## Co-investors
- [b2venture](https://shizune.co/investors/profile/btovpartners) — VC Fund, 2 deals together
- [Meusinvest (Noshaq)](https://shizune.co/investors/profile/meusinvest) — VC Fund, 2 deals together
- [Capricorn Partners](https://shizune.co/investors/profile/capricorn-partners) — VC Fund, 1 deal together
- [Gemma Frisius Fund](https://shizune.co/investors/profile/gemma-frisius-fund) — VC Fund, 1 deal together
- [imec](https://shizune.co/investors/profile/imec) — VC Fund, 1 deal together
- [Innovation Fund](https://shizune.co/investors/profile/innovation-fund-2) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [PMV](https://shizune.co/investors/profile/pmv-eu) — VC Fund
- [Limburgse Reconversie Maatschappij](https://shizune.co/investors/profile/limburgse-reconversie-maatschappij) — VC Fund
- [Qbic Fund](https://shizune.co/investors/profile/qbic-fund) — VC Fund

## Featured in investor lists
- [All Investors in Belgium](https://shizune.co/investors/investors-belgium)
- [All Angel Investors in Belgium](https://shizune.co/investors/angel-investors-belgium)
- [Health Care Investors in Belgium](https://shizune.co/investors/health-care-investors-belgium)
- [Health Care Angel Investors in Belgium](https://shizune.co/investors/health-care-angel-investors-belgium)
- [Biotech Angel Investors](https://shizune.co/investors/biotech-angel-investors)
- [Medical Angel Investors](https://shizune.co/investors/medical-angel-investors)

## FAQ

### What does Annie Vereecken invest in?

Annie Vereecken invests primarily in Medical, Biotechnology and Hospital startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Annie Vereecken's check size?

Annie Vereecken typically joins rounds of $2M–$6M at Seed and $8.2M–$30M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Annie Vereecken participates in.

### When did Annie Vereecken last invest?

The most recent investment recorded for Annie Vereecken closed in Jul 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co